These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 12112079)

  • 21. Ordered Assembly of Tau Protein and Neurodegeneration.
    Goedert M; Spillantini MG
    Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.
    Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I
    Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
    Milenkovic I; Petrov T; Kovacs GG
    Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
    Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease.
    Russ C; Lovestone S; Baker M; Pickering-Brown SM; Andersen PM; Furlong R; Mann D; Powell JF
    Neurosci Lett; 2001 Feb; 299(1-2):156-8. PubMed ID: 11166961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease.
    Ikeda K; Akiyama H; Arai T; Tsuchiya K
    Acta Neuropathol; 2002 Feb; 103(2):115-8. PubMed ID: 11810176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
    de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An autopsy case of incipient Pick's disease: immunohistochemical profile of early-stage Pick body formation.
    Miki Y; Mori F; Tanji K; Kurotaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Aug; 34(4):386-91. PubMed ID: 24444359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pick's disease is associated with mutations in the tau gene.
    Pickering-Brown S; Baker M; Yen SH; Liu WK; Hasegawa M; Cairns N; Lantos PL; Rossor M; Iwatsubo T; Davies Y; Allsop D; Furlong R; Owen F; Hardy J; Mann D; Hutton M
    Ann Neurol; 2000 Dec; 48(6):859-67. PubMed ID: 11117542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
    Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
    Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
    Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA;
    Lancet Neurol; 2024 May; 23(5):487-499. PubMed ID: 38631765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
    Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
    Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.
    Lee VM; Trojanowski JQ
    Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.